Aims When clinicians evaluate potential medications for their patients, they must weigh the
probability of a treatment's benefits against the possible risks. To this end, the present …

Modafinil (Provigil™) is a novel wakefulness-promoting agent that has been shown to have
greater efficacy than placebo in the treatment of attention-deficit hyperactivity disorder …

Background Few published reports in the dental literature have focused on adult attention-
deficit/hyperactivity disorder (ADHD) and its dental implications. Types of Studies Reviewed …

Adherence to a regular medication regimen may be challenging for adults with attention
deficit hyperactivity disorder (ADHD). Some report taking psychostimulants on a pro re nata …

Attention-deficit/hyperactivity disorder (ADHD) is commonly perceived as a childhood
disorder, but it persists into adulthood in 35% to 70% of affected people. The symptoms …

Patients with attention‐deficit/hyperactivity disorder (ADHD) often develop early onset
substance use disorder (SUD) and show poor treatment outcomes. Both disorders show …

Attention deficit hyperactivity disorder (ADHD) is one of the most common neurobehavioral
disorders affecting children. The symptoms often persist into adolescence and adulthood …

Objective: The use of central stimulant medication in adults with attention deficit hyperactivity
disorder (ADHD) who receive opioid maintenance treatment remains controversial and …

Introduction Attention-deficit/hyperactivity disorder (ADHD) is a common comorbid disorder
in patients suffering from substance use disorder (SUD). Individuals with co-occurring SUD …

Amaç: Bu çalışmada, dikkat eksikliği hiperaktivite bozukluğu (DEHB) tanısı ile izlenen
çocukların anne ve babalarındaki yaşam boyu psikopatolojinin DSM-IV ölçütlerine göre …